Antibiotic Discovery – Getting Through the Discovery Wall - CDD Webinar Video
We’re delighted to share the video and slide deck from our recent webinar featuring Dr. Lynn Silver, Dr. Johannes Zuegg (CO-ADD) and Joe Thomas (The Pew Charitable Trusts):
Antibiotic Drug Discovery is difficult for a number of reasons. Gram-negative bacteria have orthogonally permeable membranes and rapidly emergent resistance to drugs via direct mutations and horizontal gene transfer (HGT). Because of rapid emergence of resistance, it is strategic to stockpile last line antibiotics (while we have them). We would do better as a species to have a few extra antibiotics in our back pocket, in case they are needed. Our thinking is always evolving with new approaches, combinations, technologies, MOAs, and globally connected collaborations. Antibiotics are particularly interesting due to the unique market forces combing both commercial and humanitarian components.
Please listen to this provocative discussion with leading international players at the front-lines of antibiotic drug discovery: Dr. Lynn Silver (ex-Merck) and Dr. Johannes Zuegg (CO-ADD in Australia). Co-moderated by Joe Thomas (The Pew Charitable Trusts).